PRESS RELEASE
Apr 02, 2024
BioStem Technologies to Present at the 14th Annual LD Micro Invitational Conference
Apr 01, 2024
Biostem Technologies, Inc. (BSEM) Q4 2023 Earnings Call Transcript
Apr 01, 2024
BioStem Technologies Reports Fourth Quarter Revenue of $11.5 Million, 14-Fold YoY Increase
Mar 21, 2024
BioStem Technologies to Report Fourth Quarter 2023 Financial Results on Monday, April 01, 2024
Feb 26, 2024
PRISM MarketView Spotlights BioStem Technologies in the Expanding Wound Care Market
Jan 30, 2024
Amniowrap2™ Product Launch Leads Year of Highlights for BioStem Technologies
Jan 11, 2024
BioStem Technologies Appoints Proven Life Science Sales Leader Shawn McCarrey to Chief Commercial Officer Role
Dec 19, 2023
BioStem Technologies Appoints Executive Leader Patrick Daly to Board of Directors
Dec 14, 2023
Center for Medicare Services Established National Pricing of AmnioWrap2 (TM) in All MAC Regions
Dec 14, 2023
Center for Medicare Services Established National Pricing of AmnioWrap2™ in All MAC Regions